 | Webcast - Live
IMS Health at JPMorgan Healthcare Conference
01/12/09 at 2:30 p.m. PT |
As the premier source of global pharmaceutical market intelligence, we create essential value for our clients and deliver strong financial results for our shareowners. IMS (NYSE: RX) is committed to building shareowner value -- a commitment based on our reputation for leadership and innovation, our global coverage, our customer base, our unmatched data assets and our expertise. IMS's financial model is characterized by strong operating leverage, high free cash flow and a predictable revenue stream that provides our business with financial flexibility, balance sheet strength and a high return on investment for our shareholders.  |
IMS to Present at J.P. Morgan Healthcare Conference on January 12 at 2:30 p.m. PST| NORWALK, Conn.--(BUSINESS WIRE)--
IMS Health (NYSE: RX), the world’s leading provider of market
intelligence to the pharmaceutical and healthcare industries, today
announced that Leslye G. Katz, senior vice president and chief financial
officer, will speak to investors and analysts attending the J.P. Morgan
27th Annual Healthcare Conference, to be held at the Westin St. Francis
in San Francisco, CA on January 12-15, 2009.
To listen to ... |
| New Report Highlights Dramatic Change in U.S. Drug Spending Trends, Policy Implications| Researchers Use IMS Information to Assess Sales Trends, Healthcare System Opportunities and Risks
NORWALK, Conn.--(BUSINESS WIRE)--Dec. 23, 2008--A major reduction in real prescription drug spending growth has created
a "turning point" in healthcare with several policy implications,
according to a study published this month by the journal Health
Affairs as a Web Exclusive. The report, "Prescription Drug Spending
Trends in the United States: Looking Beyond the T... |
| New Study Highlights Rising Number of Type 2 Diabetes Patients in U.S., Increasing Complexity of Treatments| Health Services Research Network Academics Use IMS's Extensive Information Assets to Assess Trends in Managing a Disease Affecting MillionsNORWALK, Conn., Nov 18, 2008 (BUSINESS WIRE) -- An increasing number of type 2 diabetes patients in the U.S. are being
treated by a progressively complex mix of therapies, according to a
study featured in Archives of Internal Medicine, a JAMA/Archives
journal. The report is the first to be published by members of the
Health Ser... |
| IMS to Present at Credit Suisse Conference on November 12 at 10:30 a.m. MST| NORWALK, Conn.--(BUSINESS WIRE)--Nov. 5, 2008--IMS Health (NYSE:
RX), the world's leading provider of market intelligence to the
pharmaceutical and healthcare industries, today announced that Leslye
G. Katz, senior vice president and chief financial officer, will speak
to investors and analysts attending the 2008 Annual Credit Suisse
Health Care Conference, to be held at the Arizona Biltmore Resort &
Spa in Phoenix, AZ on November 11-14, 2008.
To listen to a live audio Webcast of ... |
|
|
| |
|
|
